Officials at Bracco say the company is expanding into the cell therapy space using its expertise with its microbubble technology. Bracco’s new lipid-based microbubble technology is designed to simplify key upstream steps in cell therapy manufacturing, offering a bead-free alternative to traditional magnetic bead approaches for cell enrichment and activation, explains CEO Fulvio Renoldi Bracco, CEO, Bracco Imaging.
Bracco will be engaging with technology developers, academic and translational research groups, and process development teams at cell therapy companies to evaluate the performance of this novel application of its microbubble technology across a range of use cases, he adds.
Cell selection remains a critical but often constraining step in cell therapy development, particularly as programs move beyond standard CD3 enrichment and toward more complex or…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
